Trump Owns Eli Lilly Stock While Regulating Drug Prices - The Receipts

Tonight we name names. According to documents obtained by Kaiser Family Foundation Health News, President Trump personally held Eli Lilly stock outside of a blind trust while his administration advanced policies benefiting the drug maker. Lilly stock has doubled since 2023, with disclosures showing between $500K-$1M in Lilly shares alone, plus holdings in Pfizer, Merck, and Bristol Myers - roughly $10 million in pharma personally while overseeing the agencies that regulate them. Our panel breaks down the 1962 loophole that exempts presidents and VPs from federal conflict of interest laws, the toothless executive order on drug pricing that Wall Street saw through in an hour, and CEO David Ricks's seven White House meetings since January. Dr. Oz now runs Medicare. Mehmet Oz announced no real negotiation on Lilly's biggest drugs. Mounjaro just got added to Medicare coverage - taxpayers now buying it, stock jumped again. We remember Cole Schmidtnecht, 22, who rationed insulin after a $500 cash substitute he couldn't afford. Six days later he died. The same week, Lilly stock hit an all-time high. This is a non-monetized community effort. Call your senator. Close the loophole. Check the receipts yourself. Watch the full video: https://iframe.mediadelivery.net/embed/672638/25c89838-9237-4924-b747-aa3291ed9fe6